Memantine and Adamantine KLVFF Conjugates: Synthesis, Ab interaction and Effects on Recognition Memory in Mice.

Adamantane derivatives, such as memantine (Mem) and amantadine (Ada), are clinically active drugs with distinct mechanisms of action and therapeutic applications.While Ada is primarily used as an antiviral and anti-Parkinson drug and is not reported to have significant pro-cognitive effects, Mem has been demonstrated to be effective in various clinical conditions characterized by cognitive deficits, including Alzheimer's disease (AD).In our mind, preserving Ab monomers from being recruited into oligomers may represent a viable therapeutic approach in AD.We designed and characterized two peptide conjugates of the KLVFF fragment bearing a memantinyl (Mem-Succ-KLVFF; Mem=3,5-dimethyladamantan-1amine,) or an amantadinyl (Ada-Succ-KLVFF; Ada=Adamantan-1-amine) moiety, linked to the KLVFF sequence through a succinyl spacer.Their ability to counteract in vitro Ab fibrillogensis and in vivo enhancement of memory performance was investigated REFERENCES

Authors

Publication Details

Published
2024-09-20
DOI
https://doi.org/10.17952/37eps.2024.p2209
Primary Topic
Eicosanoids and Hypertension Pharmacology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Memantine and Adamantine KLVFF Conjugates: Synthesis, Ab interaction and Effects on Recognition Memory in Mice.

Giuseppe Di Natale, Stefania Zimbone, Giuseppina Sabatino, Graziella Vecchio et al.
Eicosanoids and Hypertension Pharmacology
article

Memantine and Adamantine KLVFF Conjugates: Synthesis, Ab interaction and Effects on Recognition Memory in Mice.

Giuseppe Di Natale, Stefania Zimbone, Giuseppina Sabatino, Graziella Vecchio, Maria Laura Giuffrida, Giuseppe Pappalardo, Eleonora Bocchieri
article en

Abstract

Adamantane derivatives, such as memantine (Mem) and amantadine (Ada), are clinically active drugs with distinct mechanisms of action and therapeutic applications.While Ada is primarily used as an antiviral and anti-Parkinson drug and is not reported to have significant pro-cognitive effects, Mem has been demonstrated to be effective in various clinical conditions characterized by cognitive deficits, including Alzheimer's disease (AD).In our mind, preserving Ab monomers from being recruited into oligomers may represent a viable therapeutic approach in AD.We designed and characterized two peptide conjugates of the KLVFF fragment bearing a memantinyl (Mem-Succ-KLVFF; Mem=3,5-dimethyladamantan-1amine,) or an amantadinyl (Ada-Succ-KLVFF; Ada=Adamantan-1-amine) moiety, linked to the KLVFF sequence through a succinyl spacer.Their ability to counteract in vitro Ab fibrillogensis and in vivo enhancement of memory performance was investigated REFERENCES

Openalex Percentile: Top 83%
Eicosanoids and Hypertension Pharmacology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.